Looking for Low Cost Wegovy? Here's How UK Private Pricing Really Works

What NICE says about Wegovy, and why that shapes what you pay privately

NICE recommends semaglutide (Wegovy) for weight management under technology appraisal TA875, but with significant conditions: a maximum treatment duration of two years, delivery within a specialist weight management service offering multidisciplinary support, and a BMI threshold of 35 or above with at least one weight-related comorbidity. For many people those NHS conditions mean long waits, or simply not qualifying at this stage of the phased rollout. Private providers exist precisely for that gap, but if you want to understand what Wegovy costs across the private market, understanding why prices vary starts with what the NICE appraisal requires versus what a private prescription covers.

On the NHS, Wegovy sits within structured specialist services. Private prescriptions carry no such structural requirement, which is both the appeal and the reason clinical rigour matters so much. The NHS England guidance on weight-management injections is clear that these medicines should be accompanied by dietary and activity support, that context is worth holding when you compare providers on price alone.

As for the numbers: Eli Lilly raised Wegovy's list price from 1 September 2025, and typical private prices across the UK market since then range roughly £149 to £375 per month depending on dose and provider. Those are widely reported figures, not a promise about any particular pharmacy. The dose you're prescribed determines the pen you receive, so a lower introductory price often reflects the starting dose rather than ongoing cost.

What the advertised price often leaves out

The thing many readers feel when they start comparing Wegovy prices online is a quiet suspicion that the numbers don't quite add up. That instinct is usually right.

Headline prices commonly exclude the consultation fee, which some providers charge separately, sometimes significantly. Others add a prescription or dispensing charge per order. Delivery fees vary: some providers include next-working-day tracked shipping; others charge per parcel or use untracked post for a controlled medicine. Aftercare, dose-review support, and access to a prescriber between orders are sometimes billed as add-ons, or simply absent. A full picture of what Wegovy costs privately in the UK needs to account for all of those elements across a treatment period that may run to several months.

The dose trajectory matters too. Treatment starts at 0.25mg and titrates upward through 0.5mg, 1.0mg, 1.7mg to the 2.4mg maintenance dose, with newer 7.2mg dosing available following MHRA approval. Each step is prescribed by your clinician based on how you're responding. The starting-dose price is therefore never the full picture of what you'll spend across a course. For a sense of how individual dose-point costs compare, the cost at the 1mg stage and the 1.7mg step can look quite different from the maintenance figure.

What nume includes, and why we're not competing on cheapest

At nume, one price covers the consultation, the prescription, the treatment, next-working-day tracked delivery, and priority 7-day aftercare. No subscription. No auto-renewal. Every repeat order is clinically re-reviewed before anything is dispatched. The per-pen cost breakdown and current pricing live on our treatment page, and that's the only place we list them, not in body copy, because a decontextualised number isn't useful without knowing what it buys.

We are deliberately not the cheapest option in the market. That's a considered position, not an apology. A GPhC-registered Independent Prescriber personally reviews every consultation the same day, a real clinician reads your answers, not an automated triage system. You can verify our pharmacy on the GPhC register at registration number 9012878. Photo ID is checked, weight is verified on video, and GP notification follows GPhC guidance. All of that costs something. The question worth asking is what the cheaper option has removed to get its number down. Our clinical team overview sets out who reviews your case and how.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has warned publicly about fake weight-loss pens sold through social media and unverified online sellers, pens with no clinical oversight, no genuine supply chain, and in some cases containing entirely the wrong substance. Reporting suspect sellers through the MHRA Yellow Card scheme is open to anyone. The red flags are consistent: medicines offered without a clinical assessment, prices far below the market range, discount codes from sources you cannot verify against the GPhC register.

For a prescription-only medicine, price is not the primary test. Legitimate supply, clinical oversight, and a pharmacy you can check on the public register, those are the right criteria. If you want to understand the full landscape of Wegovy pricing in the UK before starting, or to explore whether Wegovy is the right fit for your situation, the right next step is a conversation with a prescriber. Start with a free consultation with our prescribers and they'll review your suitability the same day.